Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)

G. Montalban-Bravo, X. Huang, K. Naqvi, E. Jabbour, G. Borthakur, C. D. DiNardo, N. Pemmaraju, J. Cortes, S. Verstovsek, T. Kadia, N. Daver, W. Wierda, Y. Alvarado, M. Konopleva, F. Ravandi, Z. Estrov, N. Jain, A. Alfonso, M. Brandt, T. SneedH. C. Chen, H. Yang, C. Bueso-Ramos, S. Pierce, E. Estey, Z. Bohannan, H. M. Kantarjian, G. Garcia-Manero

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials (Leukemia, (2017), 31, 2, (318-324), 10.1038/leu.2016.303)'. Together they form a unique fingerprint.

Medicine & Life Sciences